I say the current system is acceptable as long as exclusive manufacture is suspended after 20 years. No matter the delivery system, the original drugmaker can’t prevent generics from being produced after that date. Royalties would still have to be paid within 40 years of the original FDA approval.
20 years is too long, make it 5. These corporations make billions in those 20 years they can more than afford to scale that shit back and make a paltry few hundred million instead. Imo that would also be an incentive to continue developing new medication that can then also be exclusive for 5 years. Maybe, I’m not an economist.
You mean incentivise them to innovate instead of letting them sit back and rake in the profits for decades? Are you actually trying to benefit the public sector instead of the private one!? Madness!!!
I say the current system is acceptable as long as exclusive manufacture is suspended after 20 years. No matter the delivery system, the original drugmaker can’t prevent generics from being produced after that date. Royalties would still have to be paid within 40 years of the original FDA approval.
20 years is too long, make it 5. These corporations make billions in those 20 years they can more than afford to scale that shit back and make a paltry few hundred million instead. Imo that would also be an incentive to continue developing new medication that can then also be exclusive for 5 years. Maybe, I’m not an economist.
You mean incentivise them to innovate instead of letting them sit back and rake in the profits for decades? Are you actually trying to benefit the public sector instead of the private one!? Madness!!!